• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Rocket Lab Announces Fourth Quarter and Full Year 2023 Financial Results, Issues Guidance for the First Quarter 2024 Including Sequential Revenue Growth Greater than 50 Percent

    2/27/24 4:05:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today shared the financial results for fiscal fourth quarter and full year, ended December 31, 2023.

    Rocket Lab founder and CEO, Peter Beck, said: "Rocket Lab had another strong year in 2023 across our launch and space systems businesses. We grew revenue 16% year-on year, while expanding our GAAP and non-GAAP gross margins by 12.0 and 6.9 percentage points, respectively, and rounded out the fourth quarter with our largest contract – an award up to $515 million from the Space Development Agency which will see us act as prime contractor for the first time to build 18 satellites for the Tranche 2 Transport Layer-Beta. We also reached a new annual launch record, with ten Electron missions flown in 2023. It was also a record year for securing Electron and HASTE contracts, with 25 new orbital and suborbital missions signed in 2023. We rounded out the year with some significant milestones for Neutron development, including the opening of a new manufacturing complex in Baltimore that will support the production of Neutron's carbon composite structures, and Archimedes engine development entered the final stages ahead of the first hot fire. Continuing this strong momentum, we started 2024 off strong with the issuance of $355 million in convertible senior notes, adding additional funding to the Rocket Lab balance sheet at an attractive cost of capital and enabling us to take advantage of potential M&A as well as other strategic growth investment opportunities."

    Fourth Quarter 2023 Business Highlights:

    • Selected as prime contractor by the Space Development Agency for a $515 million contract to design, build and operate 18 satellites for the Tranche 2 Transport Layer-Beta.
    • Electron successfully returned to flight in the fourth quarter, deploying a synthetic aperture radar satellite to orbit for Japanese constellation operator iQPS.
    • Closed 2023 with a record number of 25 launches signed across Electron and HASTE.
    • Progressed major infrastructure milestones at Launch Complex 3 for Neutron, including foundations for the launch mount, water tower and liquid oxygen tanks.
    • Established a Space Structures Complex in the former Lockheed Martin Vertical Launch Building in Middle River, Maryland to support the development and manufacture of carbon composite spacecraft structures and components, as well as the long-term supply of carbon composite structures for Neutron.
    • Refinanced our $100M term loan facility with Hercules Capital, into a larger, longer duration and cost-effective $120M equipment lending facility with Trinity Capital.

    Business Highlights Since December 31, 2023:

    • Successfully launched two Electron missions, including a Space Situational Awareness mission for Spire and NorthStar, as well as an orbital debris observation demonstration mission for Astroscale Japan Inc.
    • Progressed Electron's reusability program with a successful ocean splashdown and recovery in January 2024, bringing Electron's first stage back in the best condition yet.
    • Entered the commissioning phase at the Archimedes Test Complex at NASA Stennis Space Center in preparation for Neutron engine hot fires.
    • Closed an upsized offering of $355 million convertible senior notes to open up a mix of opportunities including potential M&A and other strategic growth and scaling investments.
    • Successful re-entry of Rocket Lab-built in-space manufacturing satellite developed for Varda Space Industries. The successful reentry marked the completion of the first commercial in-space manufacturing demonstration.

    First Quarter 2024 Guidance

    For the first quarter of 2024, Rocket Lab expects:

    • Revenue between $92 million and $98 million.
    • Space Systems revenue between $60 million and $65 million.
    • Launch Services revenue between $32 million and $33 million.
    • GAAP Gross Margins between 24% and 26%.
    • Non-GAAP Gross Margins between 29% and 31%.
    • GAAP Operating Expenses between $73 million and $75 million.
    • Non-GAAP Operating Expenses between $62 million and $64 million.
    • Expected Interest Expense (Income), net $1.5 million.
    • Adjusted EBITDA loss of $28 million to $30 million.
    • Basic Shares Outstanding of 490 million.

    See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q1 2024 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $12 million to $13 million in Q1 2024.

    Conference Call Information

    Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our fourth quarter, to provide our outlook for the first quarter, and other updates.

    The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events

    About Rocket Lab

    Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle and the Photon satellite platform and is developing the Neutron launch vehicle for large spacecraft and constellation deployment. From its first orbital launch in January 2018 to date, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 177 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch site in Virginia, USA. To learn more, visit www.rocketlabusa.com.

    + FORWARD LOOKING STATEMENTS

    This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release, including statements regarding our expectations of financial results for the first quarter of 2024, strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. Words such as, but not limited to, "anticipate," "aim," "believe," "contemplate," "continue," "could," "design," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "suggest," "strategy," "target," "will," "would," and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on Rocket Lab's current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab's control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including risks related to delays and disruptions in expansion efforts; delays in the development of our Neutron rocket; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased competition in our industry due in part to rapid technological development; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; general economic uncertainty and turbulence which could impact our customers' ability to pay what we are owed; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design. in engineering, in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; design and engineering flaws; launch failures; natural disasters and epidemics or pandemics; any inability to effectively integrate recently acquired assets; a US government shutdown or delays in government funding; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab's filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in Rocket Lab's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 7, 2023, and elsewhere. There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

    Notes to Editor: All dollar amounts in this press release are expressed in U.S. dollars, unless otherwise stated.

    + USE OF NON-GAAP FINANCIAL MEASURES

    We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

    + ADJUSTED EDITDA

    EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

    + OTHER NON-GAAP FINANCIAL MEASURES

    Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE MONTHS AND YEARS ENDED DECEMBER 31, 2023 AND 2022

    (unaudited; in thousands, except share and per share data)

     

     

     

    Three Months Ended December 31,

     

    Years Ended December 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenues

     

    $

    59,991

     

     

    $

    51,762

     

     

    $

    244,592

     

     

    $

    210,996

     

    Cost of revenues

     

     

    44,499

     

     

     

    49,932

     

     

     

    193,183

     

     

     

    192,006

     

    Gross profit

     

     

    15,492

     

     

     

    1,830

     

     

     

    51,409

     

     

     

    18,990

     

    Operating expenses:

     

     

     

     

     

     

     

     

    Research and development, net

     

     

    37,488

     

     

     

    15,018

     

     

     

    119,054

     

     

     

    65,168

     

    Selling, general and administrative

     

     

    25,887

     

     

     

    24,035

     

     

     

    110,273

     

     

     

    89,026

     

    Total operating expenses

     

     

    63,375

     

     

     

    39,053

     

     

     

    229,327

     

     

     

    154,194

     

    Operating loss

     

     

    (47,883

    )

     

     

    (37,223

    )

     

     

    (177,918

    )

     

     

    (135,204

    )

    Other income (expense):

     

     

     

     

     

     

     

     

    Interest income (expense), net

     

     

    (1,405

    )

     

     

    (892

    )

     

     

    (4,248

    )

     

     

    (7,799

    )

    Loss on foreign exchange

     

     

    (394

    )

     

     

    (488

    )

     

     

    (470

    )

     

     

    (4,435

    )

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    13,482

     

    Other income (expense), net

     

     

    196

     

     

     

    385

     

     

     

    3,715

     

     

     

    1,010

     

    Total other income (expense), net

     

     

    (1,603

    )

     

     

    (995

    )

     

     

    (1,003

    )

     

     

    2,258

     

    Loss before income taxes

     

     

    (49,486

    )

     

     

    (38,218

    )

     

     

    (178,921

    )

     

     

    (132,946

    )

    Benefit (provision) for income taxes

     

     

    (1,011

    )

     

     

    1,010

     

     

     

    (3,650

    )

     

     

    (2,998

    )

    Net loss

     

    $

    (50,497

    )

     

    $

    (37,208

    )

     

    $

    (182,571

    )

     

    $

    (135,944

    )

    Net loss per share attributable to Rocket Lab USA, Inc.:

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.10

    )

     

    $

    (0.08

    )

     

    $

    (0.38

    )

     

    $

    (0.29

    )

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    486,959,454

     

     

     

    473,644,862

     

     

     

    481,768,060

     

     

     

    466,214,095

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    AS OF DECEMBER 31, 2023 AND 2022

    (unaudited; in thousands, except share and per share data)

     

     

     

    December 31,

     

     

    2023

     

    2022

    Assets

     

     

     

     

    Current assets:

     

     

     

     

    Cash and cash equivalents

     

    $

    162,518

     

     

    $

    242,515

     

    Marketable securities, current

     

     

    82,255

     

     

     

    229,276

     

    Accounts receivable, net

     

     

    35,176

     

     

     

    36,572

     

    Contract assets

     

     

    12,951

     

     

     

    9,451

     

    Inventories

     

     

    107,857

     

     

     

    92,279

     

    Prepaids and other current assets

     

     

    66,949

     

     

     

    52,201

     

    Assets held for sale

     

     

    9,016

     

     

     

    —

     

    Total current assets

     

     

    476,722

     

     

     

    662,294

     

    Non-current assets:

     

     

     

     

    Property, plant and equipment, net

     

     

    145,409

     

     

     

    101,514

     

    Intangible assets, net

     

     

    68,094

     

     

     

    79,692

     

    Goodwill

     

     

    71,020

     

     

     

    71,020

     

    Right-of-use assets - operating leases

     

     

    59,401

     

     

     

    35,239

     

    Right-of-use assets - finance leases

     

     

    14,987

     

     

     

    15,614

     

    Marketable securities, non-current

     

     

    79,247

     

     

     

    9,193

     

    Restricted cash

     

     

    3,916

     

     

     

    3,356

     

    Deferred income tax assets, net

     

     

    3,501

     

     

     

    3,898

     

    Other non-current assets

     

     

    18,914

     

     

     

    7,303

     

    Total assets

     

    $

    941,211

     

     

    $

    989,123

     

    Liabilities and Stockholders' Equity

     

     

     

     

    Current liabilities:

     

     

     

     

    Trade payables

     

    $

    29,303

     

     

    $

    12,084

     

    Accrued expenses

     

     

    5,590

     

     

     

    8,723

     

    Employee benefits payable

     

     

    16,342

     

     

     

    8,634

     

    Contract liabilities

     

     

    139,338

     

     

     

    108,344

     

    Current installments of long-term borrowings

     

     

    17,764

     

     

     

    2,906

     

    Other current liabilities

     

     

    15,036

     

     

     

    22,249

     

    Total current liabilities

     

     

    223,373

     

     

     

    162,940

     

    Non-current liabilities:

     

     

     

     

    Long-term borrowings, excluding current installments

     

     

    87,587

     

     

     

    100,043

     

    Non-current operating lease liabilities

     

     

    56,099

     

     

     

    34,266

     

    Non-current finance lease liabilities

     

     

    15,238

     

     

     

    15,568

     

    Deferred tax liabilities

     

     

    426

     

     

     

    95

     

    Other non-current liabilities

     

     

    3,944

     

     

     

    3,005

     

    Total liabilities

     

     

    386,667

     

     

     

    315,917

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

    Stockholders' equity:

     

     

     

     

    Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued and outstanding shares: 488,923,055 and 475,356,517 at December 31, 2023 and December 31, 2022, respectively

     

     

    49

     

     

     

    48

     

    Additional paid-in capital

     

     

    1,176,484

     

     

     

    1,112,977

     

    Accumulated deficit

     

     

    (623,526

    )

     

     

    (440,955

    )

    Accumulated other comprehensive income

     

     

    1,537

     

     

     

    1,136

     

    Total stockholders' equity

     

     

    554,544

     

     

     

    673,206

     

    Total liabilities and stockholders' equity

     

    $

    941,211

     

     

    $

    989,123

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

    (unaudited; in thousands)

     

     

     

    Years Ended December 31,

     

     

    2023

     

    2022

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net loss

     

    $

    (182,571

    )

     

    $

    (135,944

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

    Depreciation and amortization

     

     

    29,744

     

     

     

    29,947

     

    Stock-based compensation expense

     

     

    53,461

     

     

     

    55,649

     

    (Gain) loss on disposal of assets

     

     

    (111

    )

     

     

    923

     

    Loss on extinguishment of long-term debt

     

     

    1,732

     

     

     

    —

     

    Amortization of debt issuance costs and discount

     

     

    2,904

     

     

     

    2,827

     

    Noncash lease expense

     

     

    5,787

     

     

     

    3,199

     

    Noncash income associated with liability-classified warrants

     

     

    —

     

     

     

    (13,482

    )

    Change in the fair value of contingent consideration

     

     

    1,343

     

     

     

    —

     

    Accretion of marketable securities purchased at a discount

     

     

    (4,571

    )

     

     

    (1,395

    )

    Deferred income taxes

     

     

    708

     

     

     

    (576

    )

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    1,452

     

     

     

    (9,430

    )

    Contract assets

     

     

    (3,501

    )

     

     

    (7,545

    )

    Inventories

     

     

    (15,562

    )

     

     

    (25,964

    )

    Prepaids and other current assets

     

     

    (14,586

    )

     

     

    (15,059

    )

    Other non-current assets

     

     

    (11,470

    )

     

     

    (7,072

    )

    Trade payables

     

     

    15,585

     

     

     

    (2,129

    )

    Accrued expenses

     

     

    (3,275

    )

     

     

    (3,518

    )

    Employee benefits payables

     

     

    5,484

     

     

     

    2,108

     

    Contract liabilities

     

     

    30,992

     

     

     

    22,661

     

    Other current liabilities

     

     

    (7,563

    )

     

     

    1,280

     

    Non-current lease liabilities

     

     

    (5,076

    )

     

     

    (3,686

    )

    Other non-current liabilities

     

     

    227

     

     

     

    668

     

    Net cash used in operating activities

     

     

    (98,867

    )

     

     

    (106,538

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

    Purchases of property, equipment and software

     

     

    (54,707

    )

     

     

    (42,412

    )

    Proceeds on disposal of assets, net

     

     

    3,660

     

     

     

    —

     

    Cash paid for business combinations and asset acquisitions, net of acquired cash and restricted cash

     

     

    (18,966

    )

     

     

    (65,824

    )

    Purchases of marketable securities

     

     

    (207,266

    )

     

     

    (259,567

    )

    Maturities of marketable securities

     

     

    269,204

     

     

     

    21,724

     

    Sale of marketable securities

     

     

    20,093

     

     

     

    —

     

    Net cash provided by (used in) investing activities

     

     

    12,018

     

     

     

    (346,079

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

    Proceeds from the exercise of stock options and public warrants

     

     

    2,444

     

     

     

    3,874

     

    Proceeds from Employee Stock Purchase Plan

     

     

    4,988

     

     

     

    4,380

     

    Proceeds from sale of employees restricted stock units to cover taxes

     

     

    15,995

     

     

     

    31,166

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

     

    (15,722

    )

     

     

    (31,164

    )

    Tax payment for net settled option shares

     

     

    —

     

     

     

    (444

    )

    Payment of contingent consideration

     

     

    (1,000

    )

     

     

    (5,500

    )

    Finance lease principal payments

     

     

    (336

    )

     

     

    (271

    )

    Proceeds from secured term loan

     

     

    110,000

     

     

     

    —

     

    Repayments on secured term loan

     

     

    (107,573

    )

     

     

    —

     

    Payment of debt issuance costs

     

     

    (1,427

    )

     

     

    —

     

    Net cash provided by financing activities

     

     

    7,369

     

     

     

    2,041

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    43

     

     

     

    4,372

     

    Net decrease in cash and cash equivalents and restricted cash

     

     

    (79,437

    )

     

     

    (446,204

    )

    Cash and cash equivalents, and restricted cash, beginning of period

     

     

    245,871

     

     

     

    692,075

     

    Cash and cash equivalents, and restricted cash, end of period

     

    $

    166,434

     

     

    $

    245,871

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    FOR THE THREE MONTHS AND YEARS ENDED DECEMBER 31, 2023 AND 2022

    (unaudited; in thousands)

     

    The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

     

     

     

    Three Months Ended December 31,

     

    Years Ended December 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    NET LOSS

     

    $

    (50,497

    )

     

    $

    (37,208

    )

     

    $

    (182,571

    )

     

    $

    (135,944

    )

    Depreciation

     

     

    4,571

     

     

     

    4,809

     

     

     

    16,034

     

     

     

    16,720

     

    Amortization

     

     

    3,596

     

     

     

    3,548

     

     

     

    13,710

     

     

     

    13,227

     

    Stock-based compensation expense

     

     

    10,063

     

     

     

    12,337

     

     

     

    53,461

     

     

     

    55,649

     

    Transaction costs

     

     

    30

     

     

     

    144

     

     

     

    341

     

     

     

    649

     

    Interest expense, net

     

     

    1,405

     

     

     

    892

     

     

     

    4,248

     

     

     

    7,799

     

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (13,482

    )

    Change in fair value of contingent consideration

     

     

    205

     

     

     

    (200

    )

     

     

    1,343

     

     

     

    —

     

    Performance reserve escrow

     

     

    31

     

     

     

    1,895

     

     

     

    5,457

     

     

     

    7,579

     

    Amortization of inventory step-up

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2,618

     

    (Benefit) provision for income taxes

     

     

    1,011

     

     

     

    (1,010

    )

     

     

    3,650

     

     

     

    2,998

     

    Loss on foreign exchange

     

     

    394

     

     

     

    488

     

     

     

    470

     

     

     

    4,435

     

    Accretion of marketable securities and cash equivalents purchased at a discount

     

     

    (1,179

    )

     

     

    (1,092

    )

     

     

    (4,780

    )

     

     

    (1,696

    )

    (Gain) loss on disposal of assets

     

     

    (351

    )

     

     

    891

     

     

     

    (111

    )

     

     

    923

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    (3,841

    )

     

     

    —

     

    Loss on extinguishment of debt

     

     

    1,732

     

     

     

    —

     

     

     

    1,732

     

     

     

    —

     

    ADJUSTED EBITDA

     

    $

    (28,989

    )

     

    $

    (14,506

    )

     

    $

    (90,857

    )

     

    $

    (38,525

    )

     

     

    Three Months Ended December 31,

     

    Years Ended December 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    GAAP Gross profit

     

    $

    15,492

     

     

    $

    1,830

     

     

    $

    51,409

     

     

    $

    18,990

     

    Stock-based compensation

     

     

    2,196

     

     

     

    3,857

     

     

     

    12,521

     

     

     

    17,948

     

    Amortization of purchased intangibles

     

     

    1,710

     

     

     

    1,710

     

     

     

    6,839

     

     

     

    4,782

     

    Amortization of inventory step-up

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2,618

     

    Performance reserve escrow

     

     

    1

     

     

     

    114

     

     

     

    210

     

     

     

    456

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    (2,130

    )

     

     

    —

     

    Non-GAAP Gross profit

     

    $

    19,399

     

     

    $

    7,511

     

     

    $

    68,849

     

     

    $

    44,794

     

    Non-GAAP Gross margin

     

     

    32.3

    %

     

     

    14.5

    %

     

     

    28.1

    %

     

     

    21.2

    %

     

     

     

     

     

     

     

     

     

    GAAP Research and development, net

     

    $

    37,488

     

     

    $

    15,018

     

     

    $

    119,054

     

     

    $

    65,168

     

    Stock-based compensation

     

     

    (3,828

    )

     

     

    (4,442

    )

     

     

    (21,721

    )

     

     

    (21,127

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (314

    )

     

     

    (9

    )

     

     

    (647

    )

     

     

    (3,342

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    631

     

     

     

    —

     

    Non-GAAP Research and development, net

     

    $

    33,346

     

     

    $

    10,567

     

     

    $

    97,317

     

     

    $

    40,699

     

     

     

     

     

     

     

     

     

     

    GAAP Selling, general and administrative

     

    $

    25,887

     

     

    $

    24,035

     

     

    $

    110,273

     

     

    $

    89,026

     

    Stock-based compensation

     

     

    (4,039

    )

     

     

    (4,038

    )

     

     

    (19,219

    )

     

     

    (16,574

    )

    Amortization of purchased intangibles

     

     

    (1,378

    )

     

     

    (1,494

    )

     

     

    (5,585

    )

     

     

    (4,401

    )

    Transaction costs

     

     

    (30

    )

     

     

    (144

    )

     

     

    (341

    )

     

     

    (649

    )

    Performance reserve escrow

     

     

    (30

    )

     

     

    (1,780

    )

     

     

    (5,247

    )

     

     

    (7,123

    )

    Change in fair value of contingent consideration

     

     

    (205

    )

     

     

    200

     

     

     

    (1,343

    )

     

     

    —

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    1,080

     

     

     

    —

     

    Non-GAAP Selling, general and administrative

     

    $

    20,205

     

     

    $

    16,779

     

     

    $

    79,618

     

     

    $

    60,279

     

     

     

     

     

     

     

     

     

     

    GAAP Operating expenses

     

    $

    63,375

     

     

    $

    39,053

     

     

    $

    229,327

     

     

    $

    154,194

     

    Stock-based compensation

     

     

    (7,867

    )

     

     

    (8,480

    )

     

     

    (40,940

    )

     

     

    (37,701

    )

    Amortization of purchased intangibles

     

     

    (1,692

    )

     

     

    (1,503

    )

     

     

    (6,232

    )

     

     

    (7,743

    )

    Transaction costs

     

     

    (30

    )

     

     

    (144

    )

     

     

    (341

    )

     

     

    (649

    )

    Performance reserve escrow

     

     

    (30

    )

     

     

    (1,780

    )

     

     

    (5,247

    )

     

     

    (7,123

    )

    Change in fair value of contingent consideration

     

     

    (205

    )

     

     

    200

     

     

     

    (1,343

    )

     

     

    —

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    1,711

     

     

     

    —

     

    Non-GAAP Operating expenses

     

    $

    53,551

     

     

    $

    27,346

     

     

    $

    176,935

     

     

    $

    100,978

     

     

     

     

     

     

     

     

     

     

    GAAP Operating loss

     

    $

    (47,883

    )

     

    $

    (37,223

    )

     

    $

    (177,918

    )

     

    $

    (135,204

    )

    Total non-GAAP adjustments

     

     

    13,731

     

     

     

    17,388

     

     

     

    69,832

     

     

     

    79,020

     

    Non-GAAP Operating loss

     

    $

    (34,152

    )

     

    $

    (19,835

    )

     

    $

    (108,086

    )

     

    $

    (56,184

    )

     

     

     

     

     

     

     

     

     

    GAAP Total other income (expense), net

     

    $

    (1,603

    )

     

    $

    (995

    )

     

    $

    (1,003

    )

     

    $

    2,258

     

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (13,482

    )

    Loss on foreign exchange

     

     

    394

     

     

     

    488

     

     

     

    470

     

     

     

    4,435

     

    Non-GAAP Total other expense, net

     

    $

    (1,209

    )

     

    $

    (507

    )

     

    $

    (533

    )

     

    $

    (6,789

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240227634541/en/

    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/5/24 9:49:25 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/3/24 9:39:57 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

      SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      11/12/24 4:45:55 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rocket Lab Partners With U.S. Air Force for Neutron Launch for Re-Entry Mission

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it will launch its new medium-lift reusable rocket Neutron for the U.S. Air Force Research Laboratory (AFRL) for a Rocket Cargo mission that supports point-to-point cargo transportation, establishing a new era of commercial launch capability to advance global defense logistics for the nation. The mission is scheduled for a return-to-Earth Neutron launch no earlier than 2026. The launch contract will see Neutron execute a Rocket Cargo survivability experiment under the AFRL Rocket Experimentation for Global Agile Logistics (REGAL) solicitation, an effort

      5/8/25 4:17:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Schedules Next Mission for Multi-Launch Customer iQPS

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the launch window for its next mission for multi-launch customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS). The mission, named ‘The Sea God Sees', will launch from Rocket Lab Launch Complex 1 in New Zealand during a launch window that opens on May 17, 2025. The mission will launch a single synthetic aperture radar (SAR) imaging satellite called QPS-SAR-10 (nicknamed "WADATSUMI-I" for the Japanese god of the sea) to a 575km circular Earth orbit, from where the satellite will join the rest of the iQPS constellation in providing high resolution im

      5/5/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • JMP Securities initiated coverage on Rocket Lab USA

      JMP Securities initiated coverage of Rocket Lab USA with a rating of Mkt Perform

      9/12/24 9:09:33 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Rocket Lab USA from Overweight to Equal-Weight and set a new price target of $6.00 from $8.00 previously

      7/15/24 7:47:38 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Leadership Updates

    Live Leadership Updates

    See more

    $RKLB
    Financials

    Live finance-specific insights

    See more

    $RKLB
    SEC Filings

    See more

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

      4/23/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Appoints Chief Operations Officer to Support Company Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the appointment of Frank Klein as its new Chief Operations Officer (COO), effective September 16th, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910807125/en/Rocket Lab's new Chief Operations Officer, Frank Klein. (Photo: Business Wire) Frank Klein joins Rocket Lab with more than 30 years of international manufacturing experience and leadership in the automotive industry. At Rocket Lab, Mr. Klein will lead the Company's efforts to scale manufacturing of spacecraft, launch vehicles, a

      9/10/24 7:00:00 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Former Lockheed Martin Chief Financial Officer Joins Rocket Lab Board of Directors

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that Kenneth (Ken) Possenriede has been appointed to the Company's Board of Directors. A seasoned executive with strong business and financial acumen, Mr. Possenriede joins Rocket Lab after a 35-year career at Lockheed Martin Corporation in financial leadership positions, including serving as Chief Financial Officer (CFO). "Ken's deep aerospace and defense industry experience, combined with accomplished financial leadership, adds even more horsepower to Rocket Lab's already impressive board line-up," said Rocket Lab's founder and Chief Executive Offic

      8/22/24 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Date of First Quarter 2025 Financial Results

      Rocket Lab USA, Inc. ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the first quarter 2025 following the close of the U.S. markets on Thursday, May 8, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.rocketlabusa.com/investors. About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufactu

      4/3/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Full Year & Fourth Quarter 2024 Financial Results, Posts Record Revenue Representing 26% Sequential Growth, 78% Annual Growth and 121% Year-on-Year Quarterly Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal fourth quarter, ended December 31, 2024. Rocket Lab founder and CEO, Sir Peter Beck, said: "2024 was a record-setting year for Rocket Lab, with our highest annual revenue ever posted of $436.2 million and a record Q4 2024 revenue of $132.4 million – a 382% increase compared to Q4 2021, our first full quarter following our debut on the Nasdaq as a publicly-traded company. Top achievements across launch and space systems include a record number of 16 launches for Electron in 2024 (a 60% increase in launch

      2/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 10-Q filed by Rocket Lab USA Inc.

      10-Q - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:30:52 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:17:18 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form 10-K/A filed by Rocket Lab USA Inc.

      10-K/A - Rocket Lab USA, Inc. (0001819994) (Filer)

      4/30/25 4:05:56 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $846,607 worth of shares (46,388 units at $18.25), decreasing direct ownership by 3% to 1,417,644 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:41:08 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Financial Officer Spice Adam C. sold $1,142,574 worth of shares (62,843 units at $18.18), decreasing direct ownership by 5% to 1,196,679 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:35:37 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Officer Kampani Arjun sold $626,403 worth of shares (34,113 units at $18.36), decreasing direct ownership by 6% to 574,883 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:35:28 PM ET
      $RKLB
      Military/Government/Technical
      Industrials